NPR Health - Shots

APRIL 2, 2023

Patients who have digestive symptoms only after eating red meat may have developed an allergy caused by ticks. Previously, doctors looked for symptoms such as rashes, hives and breathing troubles. Image credit: Getty Images)

Allergies 134

Allergies Doctor Doctors Development 134

pharmaphorum

DECEMBER 23, 2021

Children in England with peanut allergies could be among the first in Europe to get access to Aimmune’s oral immunotherapy Palforzia, after the drugmaker agreed a supply deal with NHS England. billion last year, is also developing immunotherapies for other indications including egg and multi-tree nut allergies.

Allergies 124

Allergies Drugs Clinical Trials Clinical Trials 124

pharmaphorum

OCTOBER 10, 2022

For the 32 million individuals in the US with food allergies, more research into symptoms, causes, and treatments has been long sought after, but historically underfunded. per person being spent on food allergy research. Luckily for those with food allergies, the food allergy sector has benefitted from this influx of funding.

Allergies 111

Allergies Marketing Production Doctor 111

BioPharma Reporter

SEPTEMBER 1, 2020

Swiss giant Nestlà is to acquire Aimmune Therapeutics, a biopharmaceutical company developing and commercializing treatments for food allergies. Aimmuneâs Palforzia is the worldâs first approved treatment for peanut allergy.

Allergies 98

Allergies Development 98

STAT News

JANUARY 18, 2023

The National Institute of Allergy and Infectious Diseases reported Wednesday that a Phase 3 clinical trial of a vaccine was stopped because the vaccine was ineffective at preventing HIV infection. The vaccine was being developed by Janssen, the vaccine division of Johnson & Johnson. Yet another experimental HIV vaccine has failed.

Clinical Trials 145

Clinical Trials Clinical Trials Vaccination Vaccine 145

Delveinsight

AUGUST 2, 2021

Peanut allergy (PA) is one of the most common food allergies that affect children in Western nations. Historically, the gold standard of the treatment for Peanut allergy constituted a strategic plan for peanut avoidance coupled with an adrenaline auto-injector (AAI) in case of contingencies.

Allergies 97

Allergies Marketing Development Trials 97

XTalks

NOVEMBER 4, 2020

It has long been known that mothers greatly influence the development of the growing fetus by not only providing nutrients through the placenta, but also a growing list of biological elements including beneficial antibodies, gut bacteria and now, allergies. Related: Red Meat Allergy Test Gets FDA Clearance.

Allergies 98

Allergies Antibody In-Vitro Development 98

NY Times

DECEMBER 25, 2020

The patient, who has a severe shellfish allergy, recovered quickly with treatment. Until now, reports of severe reactions had been linked to the Pfizer vaccine.

Vaccination 145

Vaccination Vaccine Doctor Doctors 145

XTalks

OCTOBER 6, 2022

According to the Asthma and Allergy Foundation of America, about 32 million people in the US have food allergies, which means allergy friendly food brands not only have a large audience base, but are also necessities. Partake Foods has become one of the most popular allergy friendly food brands and it recently secured $11.5

Allergies 90

Allergies Branding Production Packaging 90

Medical Xpress

NOVEMBER 15, 2022

Breastfed babies are believed to suffer fewer allergic conditions, like eczema and food allergies, than formula-fed babies; yet the reason has not been well understood.

Allergies 74

Allergies Development Medicine 74

pharmaphorum

DECEMBER 10, 2020

Moncef Slaoui, co-head of the US government’s Operation Warp Speed COVID-19 vaccine programme, made the comments after the UK drugs regulator advised those with severe allergies to avoid the vaccine. The post Coronavirus vaccine may have allergy warning in US, says expert appeared first on.

Allergies 103

Allergies Vaccination Vaccine Regulation 103

XTalks

FEBRUARY 26, 2024

The class of IgE-mediated food allergies includes 160 foods, with peanuts, milk, eggs, wheat, soy and tree nuts being the most common ones. According to the Centers for Disease Control and Prevention (CDC), almost six percent of people in the US in 2021 had a food allergy. million children and 13.6

Allergies 100

Allergies FDA Approval Drugs Protein 100

XTalks

JUNE 21, 2021

who is on a mission to help parents save their children from food allergies by providing them with a powder added to their milk bottles. Zakowski started this company because his nephew developed several severe food allergies. Related: Red Meat Allergy Test Gets FDA Clearance.

Allergies 98

Allergies Production FDA Approval Protein 98

BioSpace

AUGUST 4, 2020

emerged from stealth mode with $10 million in Series A financing and a goal to advance the company’s novel antibody therapeutics platform for the treatment of food and non-food allergies, as well as other severe allergic conditions. Startup IgGenix, Inc.

Allergies 82

Allergies Development Antibody 82

Pharmaceutical Technology

OCTOBER 6, 2022

from the US National Institutes of Health (NIH) unit National Institute of Allergy and Infectious Diseases (NIAID) to develop a prophylactic intranasal vaccine against Neisseria gonorrhoeae (NG). Leveraging its outer membrane vesicles (OMV) platform technology, Intravacc will develop the vaccine.

Vaccination 147

Vaccination Vaccine Development Bacterium 147

Medical Xpress

DECEMBER 2, 2022

The presence of food-specific IgA antibodies in the gut does not prevent peanut or egg allergies from developing in children, according to a Northwestern Medicine study published in Science Translational Medicine.

Allergies 80

Allergies Antibody Medicine Development 80

Scienmag

APRIL 20, 2021

Babies born by caesarean section to mothers of Asian descent are eight times more likely to develop peanut allergy by age three, study shows Credit: Faculty of Medicine & Dentistry, University of Alberta Researchers have found a causal link between caesarean section birth, low intestinal microbiota and peanut sensitivity in infants, and they report (..)

Allergies 86

Allergies Bacteria Medicine Development 86

Scienmag

NOVEMBER 17, 2020

Credit: Eliot Herman Food allergies are a big problem. suffer from some kind of food allergy. These allergies cost a whopping $25 billion in health care each year. About 7% of children and 2% of adults in the U.S. Then there’s the time lost at school or work.

Allergies 72

Allergies Genetics Development Research 72

Medical Xpress

APRIL 6, 2023

Black and Hispanic patients with severe allergies are less likely to get a common treatment, allergen immunotherapy, compared to white patients, according to Penn State College of Medicine researchers.

Allergies 69

Allergies Medicine Development Research 69

Pharmaceutical Technology

JUNE 28, 2022

grant from the National Institutes of Health (NIH) unit National Institute of Allergy and Infectious Diseases (NIAID) for developing a Covid-19 oral antiviral drug. award to researchers at Michigan State University to develop artificial intelligence algorithms that could predict crucial features with the evolution of viruses.

Development 147

Development Bioinformatics Drugs Allergies 147

Pharma Times

JULY 19, 2021

The latest funding round was led by Praetura Ventures with follow-on equity from the Development Bank of Wales

Allergies 123

Allergies Development 123

BioPharma Reporter

MAY 20, 2022

The National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health, has awarded a total of $577m to establish nine Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern.

Allergies 105

Allergies Drugs Development Drug Delivery 105

Medical Xpress

FEBRUARY 14, 2023

Scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have removed a major roadblock to better understanding of mpox (formerly, monkeypox).

Scientist 95

Scientist Development Allergies Genetics 95

Scienmag

JUNE 27, 2022

million grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop a low-dose, oral COVID antiviral drug that can be administered at home. . — Rensselaer Polytechnic Institute researchers Gaetano Montelione and Christopher Cioffi will use a five-year, $3.5

Development 94

Development Allergies Research Drugs 94

Trialfacts

OCTOBER 3, 2022

What if a baby is more prone to getting allergies because of poor gut immunity? The kind of bacteria in the human gut during infancy may affect the development of allergic disease later in life. An infant allergy development prevention research study is being done across multiple research sites in the United States and Australia.

Allergies 52

Allergies Development Production Research 52

Trialfacts

OCTOBER 3, 2022

What if a baby is more prone to getting allergies because of poor gut immunity? The kind of bacteria in the human gut during infancy may affect the development of allergic disease later in life. An infant allergy development prevention research study is being done across multiple research sites in the United States and Australia.

Allergies 52

Allergies Development Production Research 52

pharmaphorum

OCTOBER 27, 2021

Stallergenes Greer has teamed up with Aptar Pharma to develop a digital dimension for its allergen immunotherapy (AIT) products that it hopes will improve the chances of patients completing their treatment. ” The post Allergy specialist Stallergenes taps Aptar for digital delivery appeared first on.

Allergies 64

Allergies Drug Delivery Development Marketing 64

Scienmag

AUGUST 14, 2020

Discovery could lead to new screening tests and potential treatments Credit: Cincinnati Children’s Two common variants in the KIF3A gene increase the risk of young children having a dysfunctional skin barrier and developing the skin condition atopic dermatitis.

Allergies 97

Allergies Gene Development Dermatology 97

Medical Xpress

MAY 10, 2023

The strongest risk factor for developing asthma is the presence of allergies, but it's unclear why only some individuals with allergies go on to develop asthma.

Allergies 98

Allergies Gene Development 98

XTalks

SEPTEMBER 27, 2024

Novartis and Genentech released a pair of new TV commercials for allergy and asthma drug Xolair (omalizumab) as part of a direct-to-consumer (DTC) nationwide campaign called “Accidents Happen.” The ad highlights that despite the care parents take in handling their children’s allergies, accidental exposure can happen.

Allergies 52

Allergies Marketing FDA Approval Drugs 52

Pharmaceutical Technology

JUNE 16, 2023

The developer has tested OVX836 in four completed clinical trials. Also in the race is an mRNA-based candidate designed by the Vaccine Research Centre (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), which just entered a Phase I trial.

Vaccination 246

Vaccination Vaccine Trials Immune Response 246

World of DTC Marketing

NOVEMBER 19, 2021

government has provided Moderna with nearly $10 billion in taxpayer money for research and development and the purchase of 500 million doses of this mRNA COVID-19 vaccine. This includes almost the entire cost of clinical development. billion for the development of its vaccine and to pay for doses once approved. While the U.S.

Vaccination 44

Vaccination Vaccine Allergies Production 44

World of DTC Marketing

OCTOBER 6, 2021

SUMMARY: Via Axios – The antiviral pill that showed promising results against severe COVID-19 was initially developed at Emory University with $35 million of taxpayer grants. originally developed it to treat other viral diseases. And while it costs $17.74 The Intercept. Merck is not alone in hosing taxpayers.

Clinical Trials 198

Clinical Trials Clinical Trials Allergies Trials 198

Scienmag

APRIL 1, 2021

Early life exposure to antibotics in utero and through mother’s milk disrupts beneficial gut bacteria, compromising T-cell development, Rutgers research shows Exposure to antibiotics in utero and infancy can lead to an irreversible loss of regulatory T-cells in the colon-a valuable component of the immune system’s response toward allergens (..)

Immune Response 75

Immune Response Allergies Bacteria Development 75

Pharmaceutical Technology

FEBRUARY 3, 2023

The failure of several late-stage trials highlights the challenging nature of HIV vaccine development. Since HIV integrates with the DNA, eliminating the virus from the body is very difficult, explains David Montefiori, PhD, director of the Laboratory for AIDS Vaccine Research and Development at Duke University in Durham, North Carolina.

Vaccination 293

Vaccination Vaccine Antibody Trials 293

Scienmag

MAY 18, 2022

LA JOLLA, CA—The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), is sponsoring a major new antiviral drug development center that will be led by Scripps Research.

Allergies 90

Allergies Research Development Drugs 90

The Pharma Data

MARCH 15, 2022

Itchy allergy eyes affect an estimated 40% of Americans 1. Allergan, an AbbVie (NYSE: ABBV) company, today announced that LASTACAFT ® (alcaftadine ophthalmic solution 0.25%) is now available without a prescription for the estimated 40% of Americans 1 who live with ocular allergies. 2 Following the recent U.S.

Allergies 52

Allergies Production Containment Medicine 52